Search results
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
KRCG· 14 hours agoGovernment advisers Wednesday said it's time to update the recipe for the COVID-19 vaccines...
Anthony Fauci is not a hero
Reason.com· 11 hours agoMonday's hearing, organized by the House Oversight Committee's Select Subcommittee on the Coronavirus Pandemic, functioned as a quintessential example of...
Marjorie Taylor Greene screams that Fauci should be jailed for his ‘repulsive evil science’ in wild...
The Independent US via AOL· 3 days agoGreene screamed and raged at Fauci at a hearing of the Select Subcommittee on the Coronavirus...
F.D. Flam: Americans need COVID closure. Congress blew its chance
Journal Gazette & Times-Courier· 15 hours agoFollowing a 15-month inquiry, Republicans on the House Select Subcommittee on the Coronavirus...
FDA advisers: Target JN.1 strain in fall’s COVID vaccine
The Columbian· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
‘Ready to be home’: Kirtland Central alumna earns medical degree to serve Northern Navajo - Navajo...
Navajo Times· 19 hours agoDÁ’DEESTŁ’IN HÓTSAA – When Olivia Harris was young, Dr. Wilbur A. Tso inspired her to become a...
FDA panel recommends new COVID-19 vaccine formula for fall
United Press International via Yahoo News· 14 hours agoA U.S. Food and Drug Administration advisory panel on Wednesday recommended updating the formula for...
Opinion | The Checkup With Dr. Wen: In defense of the 6-foot social distancing rule
Washington Post· 8 hours agoDr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader questions and a summary of new ...
Marjorie Taylor Greene blames Fauci for his own death threats
Newsweek· 3 days agoFauci, who has faced repeated criticism from Republicans...COVID-19 virus that has killed more than...
Novavax's stock surges almost 300% in the past month
AOL· 11 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA) today finally set ...
